Highlights vom EULAR 2014 in Paris

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: Dr. Anja Ficjan

Klinische Abteilung für Rheumatologie und Immunologie, Universitätsklinik für Innere Medizin, Medizinische Universität Graz


1 Kaiser H, Z Rheumatol 2004; 63:430–5. DOI:10.1007/s00393-004-0649-5
2 Hutchinson D, THE EMERGENCE OF SEROPOSITIVE RHEUMATOID ARTHRITIS: WHY 19TH CENTURY PARIS? [LB0001].
3 Smolen JS et al., Ann Rheum Dis 2014; 73:492–509. doi:10.1136/annrheumdis-2013-204573
4 O’Dell JR et al., Arthritis Rheum 2013; 65:1985–94. DOI:10.1002/art.38012
5 Schiff M et al., Ann Rheum Dis 2014; 73:86–94. DOI:10.1136/annrheumdis-2013-203843
6 Emery P et al., Ann Rheum Dis Published Online First: 29 January 2014. DOI:10.1136/annrheumdis-2013-203993
7 Smolen JS et al., Lancet 2014; 383:321–32. DOI:10.1016/S0140-6736(13)61751-1
8 Tanaka Y et al., Ann Rheum Dis Published Online First: 28 November 2013. DOI:10.1136/annrheumdis-2013-204016
9 Dougados M et al., Ann Rheum Dis 2014; 73:62–8. DOI:10.1136/annrheumdis-2013-204223
10 Yun H et al., Ann Rheum Dis Published Online First: 7 March 2014. DOI:10.1136/annrheumdis-2013-204011
11 Matsumoto Y, INTAKE OF MONOUNSATURATED FATTY ACIDS AS COMPONENTS OF A MEDITERRANEAN DIET SUPPRESSES RHEUMATOID ARTHRITIS DISEASE ACTIVITY – THE TOMORROW STUDY [OP0010].
12 Clowse MEB, PREGNANCY OUTCOMES AFTER EXPOSURE TO CERTOLIZUMAB PEGOL: UPDATED RESULTS FROM SAFETY SURVEILLANCE [OP0067].
13 Studynkova JT, A PROSPECTIVE, RANDOMIZED, OPEN-LABEL, ASSESSORBLIND, MULTICENTER STUDY OF EFFICACY AND SAFETY OF COMBINED TREATMENT OF METHOTREXATE + GLUCOCORTICOIDS VERSUS GLUCOCORTICOIDS ALONE IN PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS (PROMETHEUS TRIAL), OP028.
14 Andersson H, LONG TIME EXPERIENCE WITH RITUXIMAB IN THE ANTISYNTHETASE SYNDROME WITH SEVERE LUNG DISEASE, OP0290.
15 Dejaco C, Current evidence for therapeutic interventions in Polymyalgia rheumatica (PMR): a systematic literature review informing the ACR/EULAR recommendations for the management of PMR [FRI0457].
16 Croft A, CAN WE REPLACE TEMPORAL ARTERY BIOPSY WITH CRANIAL ULTRASOUND FOR THE DIAGNOSIS OF GIANT CELL ARTERITIS? A RETROSPECTIVE COHORT STUDY OF THE DIAGNOSTIC UTILITY OF ULTRASOUND IN ROUTINE CLINICAL PRACTICE, OP0056.
17 Beyer C, SIGNATURE OF CIRCULATING MICRORNAS IN OSTEOARTHRITIS, OP0003.


UIM 06|2014

Herausgeber: o. Univ.-Prof. Dr. Günter J. Krejs, Österreichische Gesellschaft für Innere Medizin
Publikationsdatum: 2014-08-04